Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thürlimann B, Price KN, Coates AS, Hürny C, Bernhard J, Lindtner J, Collins J, Senn HJ, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Goldhirsch A. Crivellari D, et al. Among authors: gelber rd. J Clin Oncol. 2000 Apr;18(7):1412-22. doi: 10.1200/JCO.2000.18.7.1412. J Clin Oncol. 2000. PMID: 10735888 Clinical Trial.
Models for weighing benefits and toxicities.
Gelber RD, Goldhirsch A. Gelber RD, et al. Cancer Treat Res. 1992;60:189-206. doi: 10.1007/978-1-4615-3496-9_8. Cancer Treat Res. 1992. PMID: 1355986 Review. No abstract available.
Adjuvant treatment for breast cancer: the overview.
Gelber RD, Coates AS, Goldhirsch A. Gelber RD, et al. BMJ. 1992 Apr 4;304(6831):859-60. doi: 10.1136/bmj.304.6831.859. BMJ. 1992. PMID: 1392742 Free PMC article. No abstract available.
Meeting highlights: adjuvant therapy for primary breast cancer.
Glick JH, Gelber RD, Goldhirsch A, Senn HJ. Glick JH, et al. Among authors: gelber rd. J Natl Cancer Inst. 1992 Oct 7;84(19):1479-85. doi: 10.1093/jnci/84.19.1479. J Natl Cancer Inst. 1992. PMID: 1433332 Clinical Trial. No abstract available.
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Spataro V, Price K, Goldhirsch A, Cavalli F, Simoncini E, Castiglione M, Rudenstam CM, Collins J, Lindtner J, Gelber RD. Spataro V, et al. Among authors: gelber rd. Ann Oncol. 1992 Nov;3(9):733-40. doi: 10.1093/oxfordjournals.annonc.a058330. Ann Oncol. 1992. PMID: 1450062 Free article.
455 results